Dr, Rick Bright, Ph.D., is director of the Biomedical Advanced Research and Development Authority (BARDA) and acting Deputy Assistant Secretary in the Office of the Assistant Secretary for Preparedness and Response within HHS.
BARDA develops and provides medical countermeasures to man-made and natural threats including chemical, biological, radiological, and nuclear threats, pandemic influenza, and emerging infectious diseases.
BARDA meets this mission by supporting product innovation, advanced development, acquisition and stockpiling, and building manufacturing infrastructure.
Dr. Bright previously served as Director of the Influenza and Emerging Infectious Diseases Division in the BARDA where he was responsible for preparing the nation for influenza pandemics and coordinating production, acquisition and delivery of medical countermeasures during a pandemic response. In this role, he managed a portfolio of projects for advanced development of vaccines, therapeutics, diagnostics and respirator devices to aid in the response and protection against pandemic and seasonal influenza.
Dr. Bright joined BARDA in 2010 to lead the BARDA Influenza Division International Program, supporting programs to build and enhance global capacity for influenza vaccine production and evaluation in developing countries. Dr. Bright serves as an international subject matter expert on influenza, vaccines and therapeutics development and diagnostic programs. He has also serves as an advisor to the World Health Organization and the US Department of Defense.
Dr. Bright began his career in influenza vaccine and therapeutics development at the U.S. Centers for Disease Control and Prevention, Influenza Division. At the CDC, he focused on avian and human viruses from multiple perspectives including immunology and vaccine development, viral pathogenesis and molecular correlates of pathogenicity, as well as antiviral drugs and development novel assays for high throughput surveillance for resistance to antiviral drugs. Dr. Bright was a recipient of the Charles C. Shepard Science Award for Scientific Excellence.
Dr. Bright has also worked in the biotechnology industry where he serves as the Director of Immunology at Altea Therapeutics and Vice President of Research and Development and Global Influenza Programs at Novavax, Inc. In 2008, Dr. Bright joined PATH as the Scientific Director of the Influenza Vaccine Project in the Vaccine Development Global Program and the Director of the Influenza Vaccine Capacity Building Project in Vietnam. In this capacity, he provided technical leadership to accelerate the development of innovative vaccine and adjuvant candidates against influenza to ensure protection and access to vaccines for populations of developing countries.
Dr. Bright received his PhD in Immunology and Molecular Pathogenesis from Emory University (Atlanta, GA) and his BS in Biology (Medical Technology) and Physical Sciences from Auburn University (Montgomery, AL).
Dr Rick Bright Whistle Blower Complaint
The federal scientist who was ousted from his role as director of the Biomedical Advanced Research and Development Authority has filed a whistleblower complaint with the U.S. Office of Special Counsel.
Rick Bright was a high-ranking federal scientist focused on vaccine development and a deputy assistant secretary with the Department of Health and Human Services. Last month, Bright said he was transferred to a “less impactful position” at the National Institutes of Health after he was reluctant to promote the use of drugs such as hydroxychloroquine to treat COVID-19 patients.
In the complaint, Bright alleges a range of government wrongdoing by Dr. Robert Kadlec, the assistant secretary of preparedness and response at the U.S. Department of Health & Human Services, and others.
At the time of his removal, Bright said he had been ousted because of his “insistence” that the government spend funds on “safe and scientifically vetted solutions” to address the coronavirus crisis and not on “drugs, vaccines and other technologies that lack scientific merit.”
Ballon d’Or: Why Benzema Deserves The Title – Modric
As we draw closer to the much-talked Ballon D’or title, many soccer stars are now vetting for their preferred choice....
Ligue 1: Reason Why Ramos Will Not Make His Much-awaited Debut – PSG
What Mbappe’s Mother Said About His Contract Extension With PSG
Champions League: Messi Reveals What They Need To Do In PSG To Play Better
Worked So Hard, Didn’t See My Family For So Long – What Usyk Said After Defeating Anthony Joshua
EPL: Why I Left Chelsea & Joined Lyon – Emerson
Man Utd Carabao Cup Exit: What We Must Do For The Other Competitions Ahead – Bruno Fernandes
DJ Maphorisa Wants People To Declare Him The Landlord Of South African Music Industry
DJ Maphorisa is currently one of the top music producers in South African and he wants people and other celebrities...
You Be Will Replaced Soon – Somizi Tells Bongzie Amidst Rumours That They Are In A Relationship
South African media personality and actor, Somizi has finally reacted to the rumours peddling through social media that he has...
Gigi Lamayne Announces Her Departure From SA Hip Hop, Yet To Reveal The Next Genre She Taking Up
South African award-winning female rapper, Gigi Lamayne official made it open that she is leaving the hip hop genre for...
Am Catching Flights, You Catching Feelings – Mr JazziQ Says As He Celebrates 1M Instagram Followers
South African music producer, Mr JazziQ has officially upgraded his level in the photo-sharing website “Instagram” and has joined the...
Lady Du Celebrates Her Daughter’s Fifth Birthday In Style (Photos)
Lady Du’s daughter, Mia celebrated her fifth birthday yesterday and the singer had to surprise her with a breathtaking birthday...
What Universal Music Did To My Career – Heavy K
Afro House hitmaker, Heavy K has opened up on what he went through in the hands of his former record...
13-Story Residential Buiding In Taiwan Comepletly Razed Down By Fire, 46 Reportedly Dead
Taiwan: No fewer than 46 people lost their lives after a fire incident in a residential building in Southern Taiwan...